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20a Sunday, February 8, 2015epithelium prone to infection and in intestine leads to obstruction. Patients ho-
mozygous for F508del, have a tremendous variation in the severity of disease.
Recent Genome-wide association studies indicate that this variation is due to
presence of modifier genes, with SLC6A14 as the top modifier (Sun
et.al.,2012). SLC6A14 is a Naþ/Cl- dependent cationic/neutral amino-acid
transporter on the surface of lung and colonic epithelium. As both transporters
are expressed apically, we hypothesized that SLC6A14 would modify the fluid
secretory capacity of the epithelium. So in collaboration with TCP, we gener-
ated a SLC6A14 knock-out mouse. We can measure in-vivo fluid secretion in
mice, using an intestinal closed-loop assay. SLC6A14 knock-out mice ex-
hibited a decrease in cAMP stimulated fluid secretion mediated via CFTR rela-
tive to Wt control. To explore the mechanism by which this modification
occurs, we utilized a BHK heterologous expression system, overexpressing
CFTR and SLC6A14. Interestingly, the functional interaction can be recapitu-
lated in this system, suggesting that it not tissue-type dependent. Preliminary
biochemical and anion-flux studies support the hypothesis that SLC6A14
does not affect the processing or stability of Wt or F508del-CFTR proteins
rather it augments the activity of these channel proteins once localized to the
cell surface. Future studies will focus on understanding if this augmentation
is related to modification of CFTR’s phosphorylation dependent gating. These
results show a positive impact of SLC6A14 on CFTR channel function and
fluid secretion, providing an alternative drug target for CF patients.
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HVCN1 is the only mammalian voltage-gated proton channel. In human B lym-
phocytes, HVCN1 associates with the B Cell Receptor (BCR) and is required
for optimal BCR signaling and redox control. HVCN1 is expressed in malig-
nant B cells that rely on BCR signaling, such as Chronic Lymphocytic Leuke-
mia (CLL) cells. Compared with normal B lymphocytes, HVCN1S expression
is higher in B-cell lines and in B cells from patients with Chronic Lymphocytic
Leukemia. We found that HVCN1 was expressed in B cells as two protein iso-
forms. The shorter isoform (HVCN1S) was enriched in B cells from a cohort of
76 CLL patients. When overexpressed in a B-cell lymphoma line, HVCN1S re-
sponded more profoundly to PKC-dependent phosphorylation. This more
potent enhanced gating response was mediated by increased phosphorylation
of the same residue responsible for enhanced gating in HVCN1L, Thr
29.
Although B cells from CLL patients expressed both isoforms, their PMA
response was comparable with that of cells heterologously expressing HVCN1S
alone, indicating that this isoform dominates. Furthermore, the association of
HVCN1S with the BCR was weaker, which resulted in its diminished internal-
ization upon BCR stimulation. Finally, HVCN1S conferred a proliferative and
migratory advantage, as well as enhanced BCR-dependent signaling. Overall,
our data show for the first time the existence of a shorter isoform of HVCN1
with enhanced gating that is specifically enriched in malignant B cells.
HVCN1S properties suggest it may contribute to the pathogenesis of BCR
dependent B-cell malignancies.
Support: Bennett Fellowship from Leukaemia and Lymphoma Research (MC);
GSK Oncology - BBSRC CASE PhD studentship (MB); NIH grant
R01GM102336 (TD).
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Small-conductance (KCa2) and intermediate-conductance (KCa3.1) calcium-
activated Kþ channels are voltage-independent and share a common calcium/
calmodulin mediated gating mechanism. Existing positive gating modulators
like EBIO, NS309 or SKA-31 activate both KCa2 and KCa3.1 channels with
similar potency or, as in the case of CyPPA and NS13001, selectively activate
KCa2.2 and KCa2.3 channels. We recently performed a structure activity rela-tionship (SAR) study with the aim of optimizing the benzothiazole pharmaco-
phore of SKA-31 towards KCa3.1 selectivity and have identified SKA-121
(5-methylnaphtho[2,1-d]oxazol-2-amine), which displays 41-fold selectivity
for KCa3.1 (EC50 109 nM 5 14 nM) over KCa2.3 (EC50 4.4 5 1.6 mM).
SKA-121 is 200-400 fold selective over representative KV (KV1.3, KV2.1,
KV3.1 and KV11.1), NaV (NaV1.2, NaV1.4, NaV1.5 and NaV1.7) as well
as CaV1.2 channels. SKA-121 is a typical positive-gating modulator, which
shifts the calcium-concentration response curve of KCa3.1 to the left but
also increases open probability at saturating Ca2þ concentrations. In order to
understand why introduction of a ‘‘simple’’ CH3 group in 5-position of the ben-
zothiazole/oxazol system could achieve such a significant gain in selectivity for
KCa3.1 over KCa2.3 we are currently performing site-directed mutagenesis of
the calmodulin binding domain (CaMBD) guided by structural modeling. We
used the RosettaLigand method to generate preliminary models of SKA-121
binding to our model of the KCa3.1 C-terminal CaMBD in complex with
calmodulin. Our most energetically favorable model suggests that SKA-121
is positioned in close proximity to F301, R362, V365, M368, V369, and
S372 in KCa3.1.
Supported by U54NS079202, T32-GM008799 and T32 HL 086350 from NIH.
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Microglia rapidly respond to CNS injury and disease and can assume a spec-
trum of activation states that are reflected by changes in gene expression. Clas-
sical activation (often induced by lipopolysaccharide) and alternative activation
(IL4-induced) are now well studied but less is known about acquired de-
activation in response to IL10. Here, we are addressing how microglial
activation states affect their migration and invasion; crucial functions in the
developing CNS and after injury in adults.
We found that LPS-treated rat microglia migrate very poorly; whereas, IL4- or
IL10-treated cells migrated and invaded much better than resting cells. Never-
theless, there were similarities and differences in gene induction by IL4 and
IL10. The lamellum of migrating microglia contains a large ring of podoso-
mes_microscopic structures that are thought to mediate adhesion, migration
and invasion. IL10 (not IL4) increased podosome expression.
Then, based on the observed enrichment of SK3 Ca2þ-activated potassium
channels in podosomes, we predicted that it regulates migration and invasion.
KCNN3 (SK3) expression was similar under all three activation conditions and
KCa2.3 currents were observed. A surprising finding was that, of the three SK3
inhibitors tested (apamin, tamapin, NS8593); only NS8593 reduced the migra-
tion and invasion of IL4- or IL10-activated microglia. Surprisingly, in addition
to blocking SK3, we found that NS8593 blocked TRPM7 channels in micro-
glia. We confirmed that TRPM7 (not SK3) regulates migration and invasion
by using a TRPM7 inhibitor (AA-861) that does not block SK3 channels.
We conclude that TRPM7 (not SK3) contributes to the enhanced ability of mi-
croglia to migrate and invade when in anti-inflammatory states. This will be an
important consideration in the current efforts to develop TRPM7 inhibitors for
treating CNS injury.
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Retigabine is the prototypical member of a recently discovered class of anti-
epileptic drugs that act by potentiating the neuronal M-current formed by
KCNQ2-5 potassium channel subunits. Retigabine interacts with the pore of
KCNQ2-5 channels, requiring a Trp residue present in KCNQ2-5 to exert its
effects, suggesting the notion of a hydrophobic binding pocket. We have
used nonsense suppression to subtly alter the properties of this Trp residue
(265) in homomeric KCNQ3 channels and identify the specific chemical inter-
actions required for retigabine effects. Remarkably, simply changing the posi-
tion of the indole nitrogen atom from Trp265 (removing its hydrogen bonding
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that retigabine interacts with KCNQ channels via a hydrogen bond with the
Trp indole group, a rarely demonstrated mode of drug:target interaction. Sup-
porting this model, substitution with fluorinated Trp analogs can strengthen re-
tigabine potency by increasing the indole N-H bond polarity. Lastly, the
potency of numerous retigabine analogs for KCNQ3 channels was found to
correlate with the negative electrostatic surface potential of a conserved
carbonyl oxygen atom. These findings demonstrate the detailed chemical inter-
actions and functional groups that likely underlie the effects of retigabine and
other KCNQ activators, highlighting a rarely observed mode of drug interaction
with multifunctional amphipathic Trp side chains. These stringent constraints
for models of retigabine interactions with KCNQ channels may guide the
rational development of improved retigabine derivatives.
Platform: Kinesins, Dyneins, and Other MT-
based Motors
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Kinesin-5 slides antiparallel microtubules apart during mitosis and is necessary
for bipolar spindle formation. Besides its unique homotetrameric configuration,
determined by the coiled-coil domain, kinesin-5 motor domains also possess
specific properties optimal for their spindle organizing function. To study
properties intrinsic to the kinesin-5 motor domain, we generated functional
kinesin-5 dimers by fusing the kinesin-5 head and 18-residue neck linker to
the coiled-coil rod of kinesin-1. In ATP this kinesin-5 dimer decorated plus-
ends of taxol-stabilized microtubules and slowed depolymerization of
GMPCPP microtubules. On dynamic microtubules, kinesin-5 dimer increased
the microtubule growth rate by more than a factor of two and reduced the ca-
tastrophe frequency three-fold. These findings are consistent with kinesin-5
acting as a microtubule polymerase. To understand this polymerase mecha-
nism, TIRF microscopy was used to visualize individual GFP-labeled kine-
sin-5 dimers on immobilized microtubules. Motors walked to the ends of
microtubules and remained bound there for 7 seconds, much longer than the
0.1 s motor step time. We hypothesize that kinesin-5 promotes microtubule
polymerization by stabilizing longitudinal interactions between tubulin sub-
units on a single protofilament. Consistent with this protofilament stabilization
hypothesis, fluorescence analysis suggests that microtubule plus-ends are more
tapered in the presence of kinesin-5. Furthermore, curved and looped ends were
observed, which occasionally resolved into straight microtubules, consistent
with kinesin-5 stabilizing long protofilament bundles. In cells, these end-
binding and polymerase activities should enhance the ability of kinesin-5 to
establish and maintain spindle pole separation during mitosis.
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Mammalian KIF3AC is a heterotrimeric kinesin-2 that is best known for roles
in organelle transport and remodeling of the microtubule cytoskeleton in
neuronal tissue, yet in vitro studies to characterize its single molecule
behavior are lacking. We report that a bacterially expressed native sequence
of KIF3AC is highly processive with run lengths matching those exhibited by
conventional kinesin-1 K560 in comparative experiments. This result was un-
expected because KIF3AC exhibits the canonical kinesin-2 neck linker
sequence that has been reported to be responsible for shorter run lengths
observed for kinesin-2 KIF3AB. However, a comparative KIF3AB engi-
neered with native sequence also exhibited long run lengths suggesting that
neck linker length is not the sole determinant of run length for native
kinesin-2 motors. KIF3C contains a long extension in surface loop L11 not
present in KIF3A or KIF3B, or other processive kinesins. L11 is a component
of the kinesin microtubule interface and has been implicated in activation of
ADP release upon microtubule collision. KIF3AC encoding a truncation in
KIF3C L11 (KIF3ACL11) is even more processive than wildtype KIF3AC
and more similar to KIF3AB, suggesting that L11 also plays a role in deter-
mining run length. Steady-state ATPase experiments show that shorteningL11 does not alter the kcat, consistent with the observation that single mole-
cule velocities are not affected by this truncation. However, shortening L11
does significantly increase microtubule affinity in these dimers. Analysis of
homodimeric KIF3CC and KIF3CCL11 reveal that both are processive but
exceedingly slow. These results reveal that processivity can be regulated in
part by L11, consistent with the interpretation that L11 becomes ordered
upon microtubule collision to activate ADP release. These studies also
expand our understanding of motor processivity and point to alternative struc-
tural and mechanistic modulators of processivity. Supported by NIH R37-
GM54141.
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Eg5 is a human kinesin-5 that drives spindle pole separation during the early
phases of mitosis. While a substantial body of work has revealed the role
that Eg5 plays during mitosis, relatively little is known about how Eg5 activity
is regulated throughout the cell cycle. Our data shows that endogenous Eg5 in
HEK cells is phosphorylated on tyrosine residues. In silico predictors suggest
three tyrosines in the Eg5 motor domain as targets of Src kinase phosphoryla-
tion. We show that these residues are phosphorylated specifically by Src kinase,
but not by Wee1 kinase in vitro. Furthermore, cells expressing Eg5 constructs
with a phosphomimetic mutation of Y211 to glutamate (Y211E) show signifi-
cantly higher percentages of monopolar spindles than cells expressing wild-
type Eg5. The Y211E mutation also significantly decreases Eg5 ATPase rates
and motility in vitro. The proximity of the potential phosphorylation sites to the
binding sites of small molecule inhibitors targeting Eg5 suggested that phos-
phorylation may interfere with drug binding. Isothermal calorimetry experi-
ments show that phosphomimetic Eg5 constructs have significantly
decreased affinity for S-trityl-L-cysteine (STLC). Together, these data suggest
a role for the mitotic kinase Src in regulating Eg5 throughout the cell cycle by
directly altering its motor characteristics. Such a role for post-translational
modifications has not yet been investigated in Eg5. Additionally, the effect
of phosphomimetic mutations on STLC binding suggests that phosphorylation
may decrease the efficacy of Eg5 inhibitors that are currently in clinical trials.
Future work will seek to confirm Src kinase as a regulator of Eg5 activity in
cells and investigate phosphorylation as a potential cancer resistance
mechanism.
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Experimental systems have long been demanded for the study of collective
motion often observed in biology (flocking of birds, cell migrations during
development etc). In vitro motility assays commonly used in protein-motors’
biophysics now fulfill the demand described above. Using the in vitro motility
assays, we reported collective motion and emergence of vortices of microtu-
bules (MTs) driven by axonemal dynein [Sumino et al., Nature 483, 448-452,
2012]. Recently, we found that under various experimental conditions, the
collective motion of MTs can display nematic order, millimeter-scale
meandering streams or millimeter-scale vortices. To explore the conditions
causing such phase-shifts, we use different types of dynein (dynein c and g
of Chlamydomonas flagella) and MTs with various mean lengths. Dynein c
and g are capable of moving MTs on glass surface at velocities of ca. 12
and 6 mm/sec in the presence of 1 mM Mg-ATP at 23C, respectively.
Upon the addition of Mg-ATP, MTs start smooth gliding motions. Moving
MTs often collide each other and upon these collisions they are aligned
through nematic interactions. MTs-alignment gradually increases its size
and finally forms streams meandering across a very large distance. MTs of
less than 60-mm mean length finally generate vortices with 200-500 mm diam-
eters. On the other hand, MTs of longer than 60-mm do not form vortices. The
features of vortices generated by dynein g, i.e. number, diameter and time
needed for their emergence, are different from those in dynein c. These results
suggest that the vortex formation may reflect the mechanical properties of
inner-arm dyneins and one parameter which can modify the phase is the
length of MTs.
